Search for: "Anda Pharmaceuticals, Inc" Results 481 - 500 of 607
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2010, 12:00 am
Inc) sued Apotex for infringing three patents related to Nasonex nasal spray by submitting an ANDA for permission to market and distribute a generic version of Nasonex® . [read post]
10 Jan 2010, 8:54 pm by Patent Docs
Cobrek Pharmaceuticals, Inc. 1:10-cv-00112; filed January 7, 2009 in the Northern District of Illinois Infringement of U.S. [read post]
23 Dec 2009, 12:40 am
: Proposed amendments to Plant Variety Statute (IP Osgoode) EU: German Federal Supreme Court referral to ECJ concerning embryonic stem cells and the Biotech Directive (EPLAW) EU: Data exclusivity and food claims in Europe - Commission authorises health claim on the effect of water-soluble tomato concentrate on platelet aggregation and grants protection of proprietary data under Regulation (EC) No 1924/2006 (IPKat) France: Pharma trade marks under threat - Senate and National Assembly approve law… [read post]
20 Dec 2009, 8:16 pm by Patent Docs
APP Pharmaceuticals, LLC et al. 1:09-cv-01551; filed December 16, 2009 in the Southern District of Indiana • Plaintiff: Eli Lilly and Company • Defendants: APP Pharmaceuticals, LLC; APP Pharmaceuticals, Inc. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango)   General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill… [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech)   Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
18 Oct 2009, 5:42 pm
Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE ® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
4 Oct 2009, 4:56 pm
Endo Pharmaceuticals Inc. 1:09-cv-02589; filed October 1, 2009 in the District Court of Maryland Infringement of U.S. [read post]
26 Sep 2009, 1:57 pm
Their filing an ANDA riled AstraZeneca to assert infringement of 4,879,288. [read post]
21 Sep 2009, 2:30 am
Patent holder Eli Lilly and Company has claimed infringement by Sandoz, Inc. and others. [read post]
15 Sep 2009, 9:55 pm
Purdue originally filed suit in August 2007 in the wake of Par Pharmaceutical's filing of an Abbreviated New Drug Application (ANDA) with the FDA, claiming that Par infringed Purdue's Ultram ® patents. [read post]
13 Sep 2009, 9:31 pm
LLC • Defendants: Lupin Limited; Lupin Pharmaceuticals Inc. [read post]
20 Aug 2009, 12:52 am
Following a bench trial concerning Merck's Singulair ® patent, the court rejected Teva Pharmaceutical's validity and unenforceability defenses and concluded that Teva's ANDA applications infringed the patent-in-suit. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]